What's New

12 January 2012

The Minister for Veterans’ Affairs the Hon Warren Snowdon MP today announced the appointment of a new Repatriation Medical Authority Chairperson, Professor Nicholas Saunders.

Professor Saunders will take up the position on 1 July 2012, following the expiry of the current term of long-standing Chairperson Emeritus Professor Ken Donald AO.

A copy of the Minister’s media release is available here.

 

---

11 January 2012

At the meeting of 6 & 7 December 2011 the RMA:

Determined Statements of Principles (SoPs) for:

• conjunctivitis………………….. …….......…1/2012 & 2/2012
• acute infectious mononucleosis…..….…...3/2012 & 4/2012
• psoriatic arthropathy……………....…........5/2012 & 6/2012
• adhesive capsulitis of the shoulder.....……7/2012 & 8/2012
• aortic aneurysm…………………….....……9/2012 & 10/2012
• dementia pugilistica……………….....….…11/2012 & 12/2012

(These SoPs revoke the SoPs previously determined for these conditions).

All of the above SoPs will take effect from 11 January 2012.

These determinations conclude the previously advertised investigations into:

• conjunctivitis
• symptomatic Epstein-Barr virus infection [now known as: acute infectious mononucleosis]
• psoriatic arthropathy
• adhesive capsulitis of the shoulder
• aortic aneurysm
• dementia pugilistica
  

Download the Summary of Changes regarding SoPs 1 – 12 of 2012

         (PDF- 1020KB)     (RTF- 293KB)

---

16 December 2011

At the meeting of 6 December, the RMA:

Decided to advertise the following investigations:

• traumatic brain injury (pdf) (rtf)
• periodic limb movement disorder (pdf) (rtf)
• fibromyalgia (pdf) (rtf)
• chronic venous insufficiency of the lower limb (pdf) (rtf)

The Investigation Notices for these investigations appeared in the Government Notices Gazette of 14 December 2011.

---

 2 November 2011

At the meeting of 4 October, the RMA:

• Determined Statements of Principles (SoPs) for:
  

varicose veins of the lower limb………..………  120 of 2011 & 121 of 2011

(These SoPs revoke the SoPs previously determined for this condition).

• Determined Amendment Statements of Principles (SoPs) for:

neoplasm of the pituitary gland…………….....…122 of 2011
cerebrovascular accident…………..……...……..123 of 2011 & 124 of 2011
ischaemic heart disease...………………..…..….125 of 2011 & 126 of 2011

These determinations conclude the previously advertised investigations into:

varicose veins of the lower limb
neoplasm of the pituitary gland
cerebrovascular accident
ischaemic heart disease

All of the above SoPs will take effect from 2 November 2011.

• Determined not to amend Statement of Principles (SoPs) for:

neoplasm of the pituitary gland (RH)......................42 of 2004

This decision was made on the grounds that this SoP was amended (46/2010) on 25 February 2010 in similar terms to the above amendment  (122/2011). A Declaration of the decision will appear in the Government Notices Gazette of 2 November 2011.

Decided to advertise the following investigations:

• fibrosing interstitial lung disease (focussed review)
• arachnoid cyst of the brain
• hypothyroidism
• hyperthyroidism
• soft tissue sarcoma
• malignant neoplasm of the lung
• Paget's disease of bone
• vascular dementia
• malignant neoplasm of the breast
• osteoporosis
• seborrhoeic keratosis
• acute myeloid leukaemia
• myelodysplastic disorder
• rotator cuff syndrome
• external burn
• decompression sickness
• pulmonary barotrauma
• dysbaric osteonecrosis
• shin splints

The Investigation Notices for these investigations will appear in the Government Notices Gazette 2 November 2011

Download the Summary of Changes regarding SoPs 120 - 126 of 2011           (PDF-1026KB)     (RTF-249KB)

---

30 August 2011

At the meeting of 2 & 3 August the RMA:

• Determined Statements of Principles (SoPs) for:

• sprain and strain……………………..……………........ 94/2011 & 95/2011
• malignant neoplasm of the bladder……..…….….…... 96/2011 & 97/2011
• malignant neoplasm of the renal pelvis and ureter...... 98/2011 & 99/2011
• multiple sclerosis…….……………………………..……100/2011 & 101/2011
• renal artery atherosclerotic disease..…………...........102/2011 & 103/2011
• chronic pancreatitis……………………………………...104/2011 & 105/2011
• malignant neoplasm of bone and articular cartilage....106/2011 & 107/2011
• photocontact dermatitis…………………...…………….108/2011 & 109/2011
• irritant contact dermatitis…………………………….….110/2011 & 111/2011
• allergic contact dermatitis………………………….……112/2011 & 113/2011

(These SoPs revoke the SoPs previously determined for these conditions).

• Determined Statements of Principles (SoPs) for:

• patellar tendinopathy…………………………….…114/2011 & 115/2011
• spinal adhesive arachnoiditis…………..………….116/2011 & 117/2011
• anosmia…………………...…………………......…118/2011 & 119/2011

These determinations conclude the previously advertised investigations into:

• acute sprain and acute strain (now known as sprain and strain)
• chronic sprain and chronic strain (now known as sprain and strain)
• malignant neoplasm of the bladder
• malignant neoplasm of the renal pelvis and ureter
• multiple sclerosis
• renal artery atherosclerotic disease
• chronic pancreatitis
• malignant neoplasm of the bone or articular cartilage (now known as malignant neoplasm of bone and articular cartilage)
• photocontact dermatitis
• contact dermatitis (now known as irritant contact dermatitis)
• contact dermatitis (now known as allergic contact dermatitis)
• patellar tendinopathy
• arachnoiditis
• anosmia

All of the above SoPs will take effect from 31 August 2011.

Download the Summary of Changes regarding SoPs 94 - 119 of 2011

(PDF-1.04MB) (RTF-341KB)

---

12 July 2011

At the meeting of 14 & 15 June the RMA:

Determined Statements of Principles for:

• retinal vascular occlusive disease………83/2011 & 84/2011
• acute pancreatitis……………….…....….85/2011 & 86/2011
• extrinsic allergic alveolitis…………........87/2011 & 88/2011
• diabetes mellitus..………………….....…89/2011 & 90/2011

(These SoPs revoke the SoPs previously determined for these conditions).

Determined Amendment Statements of Principles (SoPs) for:

• malignant neoplasm of the endometrium (RH)....91/ 2011
• malignant neoplasm of the urethra (RH).............92/2011
• schizophrenia (RH)…….…....…..………….........93/2011

All of the above SoPs will take effect from 13 July2011.

Determined not to amend Statements of Principles (SoPs) for:

• malignant neoplasm of the endometrium (BoP)....100/2007
• malignant neoplasm of the urethra (BoP)…..........2/2008
• schizophrenia (BoP..…………………..................16/2009

These decisions were made on the grounds that there is no sound medical-scientific evidence available to justify an amendment. A Declaration of the decisions will appear in the Government Notices Gazette of 13 July 2011.

These determinations conclude the previously advertised investigations into:

• retinal vascular occlusive disease
• acute pancreatitis
• extrinsic allergic alveolitis
• diabetes mellitus
• malignant neoplasm of the endometrium
• malignant neoplasm of the urethra
• schizophrenia

Decided to advertise the following investigation:

• lipodermatosclerosis

The Investigation Notice for this investigation will appear in the Government Notices Gazette 13 July 2011.

Download the Summary of Changes regarding SoPs 83 - 93/2011

         (PDF - 1.01MB)     (RTF - 104KB)

---

25 May 2011

At the meeting of 5 & 6 April the RMA:

Determined Statements of Principles (SoPs) for:

• malignant neoplasm of the nasopharynx….25 & 26 of 2011
• irritable bowel syndrome…………..…....….27 & 28 of 2011
• acoustic neuroma…………………..…...….29 & 30 of 2011
• obstructive and reflux nephropathy...……..31 & 32 of 2011

(These SoPs revoke the SoPs previously determined for these conditions).

• subdural haematoma………………….…….33 & 34 of 2011 

(These SoPs are a new condition).

These determinations conclude the previously advertised investigations into:

• malignant neoplasm of the nasopharynx
• irritable bowel syndrome
• acoustic neuroma
• obstructive   nephropathy (now known as: obstructive and reflux nephropathy)
• subdural haematoma
  
  

 Determined Amendment Statements of Principles (SoPs) for:

• osteoarthritis……………………………....…..............35 & 36 of 2011
• malignant neoplasm of the brain…………….....….....37 & 38 of 2011
• malignant neoplasm of the colorectum……....….......39 & 40 of 2011
• malignant neoplasm of the lung…………..…............41 & 42 of 2011
• acute myeloid leukaemia………………….........….....43 & 44 of 2011
• myelodysplastic disorder………………….........….....45 & 46 of 2011
• chronic myeloid leukaemia……………………............47 & 48 of 2011
• malignant neoplasm of the bile duct………................49 & 50 of 2011
• malignant neoplasm of the gallbladder……................51 & 52 of 2011
• malignant neoplasm of the breast…………….............53 & 54 of 2011
• malignant neoplasm of the oesophagus….....….........55 & 56 of 2011
• malignant neoplasm of the cerebral meninges.…........57 & 58 of 2011
• cerebral meningioma……………………..…… ............59 & 60 of 2011
• malignant neoplasm of the ovary……………...............61 & 62 of 2011
• malignant neoplasm of the salivary gland…............... 63 & 64 of 2011
• malignant neoplasm of the stomach……….......….......65 & 66 of 2011
• malignant neoplasm of the thyroid gland……...............67 & 68 of 2011
• malignant neoplasm of unknown primary site…. ........ 69 & 70 of 2011
• non-melanotic malignant neoplasm of the skin.............71 & 72 of 2011
• soft tissue sarcoma…………………………..….............73 & 74 of 2011
• benign neoplasm of the eye and adnexa………............75 & 76 of 2011
• acquired cataract……………………………...................77 & 78 of 2011
• fibrosing interstitial lung disease…………….................79 & 80 of 2011
• cirrhosis of the liver………………………….…...............81 & 82 of 2011

All of the above SoPs will take effect from 25 May 2011.

Determined NOT to amend Statements of Principles (SoPs) for:

• malignant neoplasm of the small intestine…...…       40 of 2004 (as amended by 19 of 2010) & 41 of 2004.

This decision was made on the grounds that there is no sound medical-scientific evidence available to justify an amendment. A Declaration of the decision will appear in the Government Notices Gazette of 18 May 2011 and can be viewed here. (PDF-212kb) (RTF-14KB)

These determinations conclude the previously advertised ‘focussed reviews’ of each of the conditions. A summary outlining the RMA’s consideration of ionising radiation can be accessed here. (PDF -414KB) (RTF -18.20MB)

Decided to advertise the following investigations:

• fibrosing interstitial lung disease (focussed review)
• otitis media
• allergic rhinitis
• malignant neoplasm of the stomach
• mitral valve prolapse
• atrial fibrillation
• chronic fatigue syndrome
• melioidosis
• morbid obesity
• restless legs syndrome
• pleural plaque
• malignant neoplasm of the colorectum
• osteomyelitis
• tinea of the skin
• malignant neoplasm of the testis and paratesticular tissues
• hiatus hernia
• Hodgkin's lymphoma
• chronic bronchitis and emphysema
• Creutzfeldt-Jakob disease
• malignant neoplasm of the small intestine
• malignant neoplasm of unknown primary site
• malignant neoplasm of the salivary gland
• leptospirosis
• epicondylitis
• cervical spondylosis
• thoracic spondylosis
• lumbar spondylosis
• solvent related chronic encephalopathy
• peripheral neuropathy
• sudden unexpected death
• malignant neoplasm of the pancreas
• epileptic seizure
• epilepsy
• dermatomyositis
• Guillain-Barre syndrome
• steatohepatitis
• narcolepsy
• malignant neoplasm of the larynx
• heart block
• spondylolisthesis & spondylolysis
• malignant neoplasm of the thyroid gland

The Investigation Notices for these investigations appeared in the Government Notices Gazette of  18 May 2011. A copy of the Gazette notifications can be located here.

Download the Summary of Changes regarding SoPs 25 - 82 of 2011.   (PDF-1104KB) (RTF-490KB)

---

23 March 2011

At the meeting of 22 & 23 February the RMA:

 

Determined Statements of Principles (SoPs) for:

• dental malocclusion                   (17 & 18 of 2011)
• rheumatic heart disease             (19 & 20 of 2011)
• malignant neoplasm of the liver   (21 & 22 of 2011)

These SoPs revoke the SoPs previously determined for these conditions.

 

 

Determined Statements of Principles (SoPs) for:

• acute rheumatic fever                  (23 & 24 of 2011)  (new condition)

 

Determined to revoke and not reissue Statements of Principles (SoPs) for:

• metatarsalgia                              (39 & 40 of 1996)

A Declaration relating to this decision will appear in the Government Notices Gazette of 23 March 2011.

 

 

N.B. – This concludes the previously advertised investigations into:

• dental malocclusion
• rheumatic heart disease
• malignant neoplasm of the liver
• acute rheumatic fever
• metatarsalgia 

All of the above SoPs and decisions will take effect from 30 March 2011.

 

 

Decided to advertise the following investigations:

• ischaemic heart disease
• cerebrovascular accident
• hypertension
• JAK-related myeloproliferative disorders
• chronic myeloid leukemia

The Investigation Notices for these investigations will appear in the Government Notices Gazette of  23 March 2011.

 

 

Summary of Changes regarding SoPs 17 - 24 of 2011

---

5 January 2011

At the meeting of 30 November, 2010 the RMA

Determined Statements of Principles (SoPs) for:

• coeliac disease.......................1 & 2 of 2011
• varicocele................................3 & 4 of 2011
• sensorineural hearing loss........5 & 6 of 2011
• conductive hearing loss ...........7 & 8 of 2011
• Kaposi's sarcoma....................9 & 10 of 2011
• polyarteritis nodosa.................11 & 12 of 2011

These SoPs revoke the SoPs previously determined for these conditions.

• Determined Statements of Principles (SoPs) for:

• microscopic polyangiitis...........13 & 14 of 2011 - Determination from investigation into polyarteritis nodosa

N.B. – This concludes the previously advertised investigations into:

• coeliac disease
• varicocele
• sensorineural hearing loss
• conductive hearing loss
• Kaposi's sarcoma
• polyarteritis nodosa

 Determined Amendment Statements of Principles (SoPs) for:

• Anxiety disorder............15 & 16 of 2011

All of the above SoPs will take effect from 5 January 2011

 

A Summary of Changes:  SoPs 1 - 16 of 2011 is available to be downloaded.

---

22 December 2010

At the meeting of 30 November, 2010 the RMA

Decided to advertise the following investigations:

• malignant neoplasm of the bladder
• motor neurone disease
• osteoarthritis (focussed review)

The Investigation Notices for these investigations will appear in the Government Notices Gazette of  22 December, 2010.

---

10 November 2010

At the meeting of 6 October the RMA

Determined Statements of Principles (SoPs) for:

• poisoning and toxic reaction from plants and fungi - 84 & 85 of 2010
  
• schistosomiasis  - 86 & 87 of 2010
• strongyloidiasis -  88 & 89 of 2010
• Ross River virus infection  - 90 & 91 of 2010
• Morton's metatarsalgia  - 92 & 93 of 2010
• labral tear  - 94 & 95 of 2010

These SoPs revoke the SoPs previously determined for these conditions.

N.B. – This concludes the previously advertised investigations into:

• poisoning and toxic reaction from plants [now known as – poisoning and toxic reaction from plants and fungi]
• schistosomiasis
• strongyloidiasis
• Ross River fever [now known as – Ross River virus infection]
• Morton's neuroma [now known as – Morton's metatarsalgia]
• acute labrum tear [now known as – labral tear]

Determined Amendment Statement of Principles (SoPs) for:

• ischaemic heart disease - 96 & 97 of 2010

N.B. – This concludes the previously advertised investigation into:

• ischaemic heart disease
  

All of the above SoPs will take effect from 10 November, 2010.



3 November 2010

At the meeting of 6 October, the RMA

Decided to advertise the following investigations:

• inguinal hernia
• solar keratosis
• chronic lymphoid leukaemia
• gastro-oesophageal reflux disease
• sleep apnoea
• erectile dysfunction
• malignant neoplasm of the oral cavity, oropharynx & hypopharynx
• seborrhoeic dermatitis
• asbestosis
• ankylosing spondylitis
• malignant neoplasm of the prostate
• malignant neoplasm of the stomach (broadened, previously advertised focussed review)
• chronic myeloid leukaemia (broadened, previously advertised focussed review)
• malignant neoplasm of unknown primary site (broadened, previously advertised focussed review)
• malignant neoplasm of the salivary gland  (broadened, previously advertised focussed review)
• malignant neoplasm of the thyroid gland (broadened, previously advertised focussed review)
• malignant neoplasm of the breast (broadened, previously advertised focussed review)
• acute myeloid leukaemia (broadened, previously advertised focussed review)
• myelodysplastic disorder (broadened, previously advertised focussed review)
• non-melanotic malignant neoplasm of the skin (broadened, previously advertised focussed review)
• cirrhosis of the liver (broadened, previously advertised focussed review)
• benign neoplasm of the eye and adnexa (broadened, previously advertised focussed review)
• acquired cataract (broadened, previously advertised focussed review)
• schizophrenia (broadened, previously advertised focussed review)
• cerebral meningioma (broadened, previously advertised focussed review)
• malignant neoplasm of the cerebral meninges (broadened, previously advertised focussed review)
• fibrosing interstitial lung disease (broadened, previously advertised focussed review)
• malignant neoplasm of the ovary (broadened, previously advertised focussed review)
• malignant neoplasm of the colorectum (broadened, previously advertised focussed review)
• malignant neoplasm of the bladder (broadened, previously advertised focussed review)
• soft tissue sarcoma (broadened, previously advertised focussed review)
• malignant neoplasm of the lung (broadened, previously advertised focussed review)
• malignant neoplasm of the brain (broadened, previously advertised focussed review)
• malignant neoplasm of the urethra (focussed review)
• malignant neoplasm of the oesophagus (focussed review)
• malignant neoplasm of the endometrium (focussed review)
• malignant neoplasm of the bile duct (focussed review)
• malignant neoplasm of the gall bladder (focussed review)
• acute sprain and acute strain
• chronic sprain and chronic strain
• patellar tendinopathy
• acute rheumatic fever

The Investigation Notices for these investigations will appear in the Government Notices Gazette 3 November, 2010.

1 September 2010

At the meeting of 4 August 2010 the RMA


Determined Statements of Principles (SoPs) for:

• blepharitis - 63 & 64 of 2010
• renal stone disease - 65 & 66 of 2010
• subarachnoid haemorrhage - 67 & 68 of 2010
• acute sprain and acute strain - 69 & 70 of 2010
• pilonidal sinus - 71 & 72 of 2010
• anal fissure - 73 & 74 of 2010
• chronic pruritus ani - 75 & 76 of 2010
• heel bursitis - 77 & 78 of 2010
• chondromalacia patella - 79 & 80 of 2010
• rapidly progressive crescentic glomerulonephritis - 81 & 82 of 2010

These SoPs revoke the SoPs previously determined for these conditions.

N.B. – This concludes the previously advertised investigations into:

• acute blepharitis [now known as – blepharitis]
• chronic blepharitis [now known as – blepharitis]
• nephrolithiasis [now known as – renal stone disease]
• ureteric calculus [now known as – rental stone disease]
• subarachnoid haemorrhage
• acute sprain and acute strain
• pilonidal sinus
• anal fissure
• pruritus ani [now known as – chronic pruritus ani]
• posterior adventitial heel bursitis [now known as – heel bursitis]
• chondromalacia patellae [now known as – chondromalacia patella]
• rapidly progressive crescentic glomerulonephritis
  
  Determined Amendment Statement of Principles (SoPs) for:

• Parkinson's disease and parkinsonism - 83 of 2010

All of the above SoPs will take effect from 1 September, 2010.

• anosmia
• malignant neoplasm of the colorectum (focussed review)
• malignant neoplasm of the bladder (focussed review)
• malignant neoplasm of the small intestine (focussed review)
• soft tissue sarcoma (focussed review)
• malignant neoplasm of the stomach (focussed review)
• chronic myeloid leukaemia (focussed review)
• malignant neoplasm of unknown primary site (focussed review)
• malignant neoplasm of the salivary gland (focussed review)
• malignant neoplasm of the thyroid (focussed review)
• malignant neoplasm of the lung (focussed review)
• malignant neoplasm of the breast (focussed review)
• acute myeloid leukaemia (focussed review)
• myelodysplastic disorder (focussed review)
• non-melanotic malignant neoplasm of the skin (focussed review)
• cirrhosis of the liver (focussed review)
• benign neoplasm of the eye and adnexa (focussed review)
• acquired cataract (focussed review)
• malignant neoplasm of the brain (focussed review)
• schizophrenia (focussed review)
• cerebral meningioma (focussed review)
• malignant neoplasm of the cerebral meninges (focussed review)
• fibrosing interstitial lung disease (focussed review)
• malignant neoplasm of the ovary (focussed review)
• anxiety disorder (focussed review)

The Investigation Notices for these investigations will appear in the Government Notices Gazette of  1 September, 2010.

30 June 2010

At the meeting of 2 June 2010, the RMA

• determined Statements of Principles (SoPs) for:
  
  -      methaemoglobinaemia        (47 & 48 of 2010)
  -     sinus barotrauma                    (49 & 50 of 2010)
  -     internal derangement of the knee  (51 & 52 of 2010)
  -     acute articular cartilage tear        (53 & 54 of 2010)
  -     acute meniscal tear of the knee  (55 & 56 of 2010)
  -     Dupuytren's disease                (57 & 58 of 2010)

These SoPs revoke any previously determined SoPs for these conditions.

• Declared that the Repatriation Medical Authority (the Authority) does not propose to determine Statements of Principles concerning "Gulf War syndrome".  The Authority concluded it is not a 'disease' or 'injury' within the meaning of the VEA.  The Declaration will appear in the Government Notices Gazette of 30 June 2010.

 N.B. – This concludes the previously advertised investigations into:

»          methaemoglobinaemia
»          sinus barotrauma
»          internal derangement of the knee
»          acute articular cartilage tear
»          acute meniscal tear
»          Dupuytren's contracture
»          Gulf War syndrome

determined Amendment Statement of Principles (SoPs) for:

-     fibrosing interstitial lung disease (59 & 60 of 2010)
-     vascular dementia                                 (61 & 62 of 2010)

N.B. – This concludes the previously advertised investigations into:

»          fibrosing interstitial lung disease
»          vascular dementia

All of the above SoPs will take effect from 30 June, 2010.

• decided to advertise the following investigations:

• Morton's neuroma
• arachnoiditis
• dementia pugilistica
• physical injury to munitions discharge
• chloracne
• goitre
• aplastic anaemia
• dengue fever
• porphyria cutanea tarda
• inflammatory bowel disease
• tinnitus
• otitic barotrauma
• chronic pancreatitis
• pes planus
• mesangial igA glomerulonephritis
• giant cell arteritis
• otitis externa
• chronic gastritis
• acute lymphoid leukaemia
• asthma
• adenocarcinoma of the kidney
• carpal tunnel syndrome
• periodontitis
• gingivitis
• malignant neoplasm of the anal canal
• malignant neoplasm of the bone or articular cartilage
• aortic stenosis
• psoriasis
• familial adenomatous polyposis
• colorectal adenoma
• artial flutter
• dental pulp disease

The Investigation Notices for these investigations will appear in the Government Notices Gazette of  30 June, 2010.

12 May 2010

• At the meeting of 14 April the RMA
  . determined Statements of Principles (SoPs) for:
  - cluster headache (20 & 21 of 2010)
  - Alzheimer-type dementia (22 & 23 of 2010)
  - dislocation (24 & 25 of 2010)
  - reactive arthritis (26 & 27 of 2010)
  - non-Hodgkin's lymphoma (28 & 29 of 2010)
  - gout (30 & 31 of 2010)
  - joint instability (32 & 33 of 2010)
  - iliotibial band syndrome (34 & 35 of 2010)
  
  These SoPs revoke the SoPs previously determined for these conditions.
  
  N.B. – This concludes the previously advertised investigations into:
  
  cluster headache syndrome [now known as – cluster headache]
  » Alzheimer's disease [now known as – Alzheimer-type dementia]
  » dislocation
  » Reiter's syndrome [now known as – reactive arthritis]
  » non-Hodgkin's lymphoma
  » gout
  » joint instability
  » iliotibial band syndrome
   
• . determined Amendment Statement of Principles (SoPs) for:
  - lumbar spondylosis (36 & 37 of 2010)
  - intervertebral disc prolapse (38 & 39 of 2010)
  - depressive disorder (40 & 41 of 2010)
  - anxiety disorder (42 & 43 of 2010)
  - spondylolisthesis & spondylolysis (44 & 45 of 2010)
  
  All of the above SoPs will take effect from 12 May, 2010.
  
  
  
  - neoplasm of the pituitary gland (46 of 2010)
  
  This amendment, neoplasm of the pituitary gland was determined in accordance with the Specialist Medical Review Council Declaration No.13 dated 25 February 2010. Pursuant to section 196B(13) of the Veterans’ Entitlements Act (1986) the date of effect for this Instrument 46 of 2010 is 10 March 2010.
  
  
• . decided to advertise the following investigations:
  - subdural haematoma
  - acute labrum tear
  - sarcoidosis (focussed review)
  - neoplasm of the pituitary gland (focussed review)

The Investigation Notices for these investigations will appear in the Government Notices Gazette of 12 May, 2010.

10 March 2010

At the meeting of 10 February, the RMA

• determined Statements of Principles (SoPs) for:
  - sinusitis (9 & 10 of 2010)
  - suicide and attempted suicide (11 & 12 of 2010)
  - osteoarthritis (13 & 14 of 2010)
  - malignant neoplasm of the eye (15 & 16 of 2010)
  - accidental hypothermia (17 & 18 of 2010)
  
  These SoPs revoke the SoPs previously determined for these conditions.
  
  All of the above SoPs will take effect from 10 March, 2010
  
  N.B. – This concludes the previously advertised investigations into:
  » acute sinusitis [now known as – sinusitis]
  » chronic sinusitis [now known as – sinusitis]
  » chronic rhinosinusitis [now known as – sinusitis]
  » suicide or attempted suicide [now known as – suicide and attempted suicide]
  » osteoarthrosis [now known as – osteoarthritis]
  » malignant neoplasm of the eye
  » accidental hypothermia
  
  
• determined Amendment Statement of Principles (SoPs) for:
  - malignant neoplasm of the small intestine (19 of 2010)
  
  This amendment was determined in accordance with the Specialist Medical Review Council Declaration No.12 dated 29 June 2009. Pursuant to section 196B(13) of the Veterans’ Entitlements Act (1986) the date of effect for this Instrument 19 of 2010 is 19 August 2009.
  
  
• decided to advertise the following investigation:
  - acute meniscal tear

The Investigation Notice for this investigation will appear in the Government Notices Gazette of 10 March, 2010

12 January 2010

At the meeting of 9 December 2009, the RMA

• determined Statements of Principles (SoPs) for:
  - tension-type headache (1 & 2 of 2010)
  - herpes simplex (3 & 4 of 2010)
  - human immunodeficiency virus (5 & 6 of 2010)
  - human t-cell lymphotropic virus type-1 (7 & 8 of 2010)
  
  These SoPs revoke the SoPs previously determined for these conditions.
  All of the above SoPs will take effect from 13 January, 2010.
  
  N.B. – This concludes the previously advertised investigations into:
  » tension-type headache
  » herpes simplex
  » human immunodeficiency virus
  » human t-cell lymphotropic virus type-1
   
  
• decided to advertise the following investigations:
  - rapidly progressive crescentic glomerulonephritis
  - myeloma
  - spondylolisthesis & spondylolysis (focussed review)

The Investigation Notices for these investigations will appear in the Government Notices Gazette of 13 January, 2010.

23 December 2009

At the meeting of 9 December 2009, the RMA

• decided to advertise the following investigations:
  - joint instability
  - acute strain and acute sprain

The Investigation Notices for these investigations appeared in the Government Notices Gazette of 23 December, 2009.

6 November 2009

At the meeting of 14 October 2009, the RMA

• determined Statements of Principles (SoPs) for:
  - panic disorder (68 & 69 of 2009)
  - malignant neoplasm of the ovary (70 & 71 of 2009)
  - scrub typhus (72 & 73 of 2009)

These SoPs revoke the SoPs previously determined for these conditions.

• determined SoPs for the following new conditions:
  - adrenal insufficiency (74 & 75 of 2009)
  - hypopituitarism (76 & 77 of 2009)

All of the above SoPs will take effect from 11 November 2009.

N.B. – This concludes the previously advertised investigations into:

» panic disorder
» malignant neoplasm of the ovary
» scrub typhus
» Addison’s disease (now known as adrenal insufficiency)
» hypopituitarism

• decided to advertise the following investigations:
  - acute articular cartilage tear
  - fibrosing interstitial lung disease
  - Parkinson’s disease and parkinsonism (focussed review)
  - ischaemic heart disease (focussed review)
  - vascular dementia (focussed review)
  - pulmonary thromboembolism

The Investigation Notices for these investigations appeared in the Government Notices Gazette of 4 November, 2009.

2 September 2009

At the meeting of 4 August 2009, the RMA

• determined Statements of Principles (SoPs) for:
  - trigeminal neuralgia (54 & 55 of 2009)
  - migraine (56 & 57 of 2009)
  - influenza (58 & 59 of 2009)
  - malaria (60 & 61 of 2009)
  
  These SoPs revoke the SoPs previously determined for these conditions.
  
  
• determined SoPs for the following new conditions:
  - bronchiolitis obliterans organising pneumonia (62 & 63 of 2009)
  - systemic sclerosis (64 & 65 of 2009)
  - localised sclerosis (66 & 67 of 2009)
  
  All of the above SoPs will take effect from 2 September 2009.
  
  N.B. – This concludes the previously advertised investigations into:
  » bronchiolitis obliterans organising pneumonia
  » trigeminal neuralgia
  » migraine
  » influenza
  » malaria
  » scleroderma (now known as systemic sclerosis and localised sclerosis)
  
  
• decided to advertise the following investigations:
  - iliotibial band syndrome
  - Dupuytren's contracture
  
  The Investigation Notices for these investigations appeared in the Government Notices
  Gazette of 26 August, 2009.
  
  
• decided to publish declarations concerning focussed investigations into
  "anxiety spectrum disorders" with respect to the following conditions:
  - rheumatoid arthritis
  - polymyalgia rheumatica
  - inflammatory bowel disease
  - diabetes mellitus
  - cerebrovascular accident
  
  N.B. – The publication of these declarations finalises the focussed investigations
  previously advertised and confirms no change to the existing SoPs.

 

2010 Repatriation Medical Authority | Legal | Comments to the Webmaster